stockrow
Friday 6 November 2026
Export BVS’s income statement to Excel — free account
Bioventus Inc.
BVS Healthcare Medical Devices
Bioventus Inc.’s revenue for fiscal 2025 (year ended December 2025) was $568.1 million, down 0.91% from fiscal 2024.
- Revenue
- +2.73%
- EPS
- +100.6%
- Free cash flow
- −31.4%
- Total debt
- −28.8%
Quarter to September 2026, against a year earlier
10.68
0.00
0.00%
Follow BVS
Alert me
Bioventus Inc. (BVS) P/E ratio
As of 6 November 2026, Bioventus Inc. (BVS) trades at a P/E ratio of 12.4×. Over the past ten years it has ranged from 0.0× (September 2025) to 64.9× (November 2025); the current reading is higher than 64% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 21.9× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 32.4× | 47.97% |
| FY2020 | 21.9× | 0.00% |
| FY2019 | 21.9× | 0.00% |
| FY2018 | 21.9× | 0.00% |
| FY2017 | 21.9× | 0.00% |
| FY2016 | 21.9× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 15.8× | 35.94% |
| Jun 2026 | 11.7× | (45.11%) |
| Mar 2026 | 21.2× | (2.97%) |
| Dec 2025 | 21.9× | (60.75%) |
| 24 more quarters | Free account |
Against its own ten years
Low 0.0×
High 64.9×
Ten-year median
0.0×
Current reading's percentile
64
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CBLL CeriBell, Inc. compare | n/m |
| BBNX Beta Bionics, Inc. compare | n/m |
| AHCO AdaptHealth Corp. compare | n/m |
| SIBN SiBone compare | n/m |
| QDEL QuidelOrtho Corporation compare | n/m |
| KIDS OrthoPediatrics Corp. compare | n/m |
| INMD InMode Ltd. compare | 10.7× |
| BVS Bioventus Inc. | 12.3× |
| IRMD iRadimed Corporation compare | 44.9× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)